Abstract
BackgroundFour new disease specific composite disease activity measures have been developed for psoriatic arthritis (PsA). Further validation of these measures in interventional trial data is now required.ObjectivesThe objective of this...
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have